Rexulti, the first drug to relieve Alzheimer's emotions - TimesKuwait

The US Food and Drug Administration (FDA) has granted fast-track approval of the first drug aimed at relieving the emotions associated with Alzheimer’s disease. The FDA published, on its official website, a statement confirming the approval of Otsuka Pharmaceutical Company and Lundbeck, producers of oral Rexulti tablets to relieve the emotions associated with Alzheimer’s disease, […]

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

The Madness of Pop Psychiatry - by Nick Jikomes, PhD

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

FDA approves Rexulti for agitation tied to Alzheimer's dementia, Daily therapy is first to be approved for this use in US

Positive Data for First and Only Treatment Approved for Agitation in Alzheimer Dementia

FDA clears Rexulti as first drug for Alzheimer's agitation

Drug repurposing for Alzheimer's disease: Selective serotonin reuptake inhibitors - Rao - 2020 - Alzheimer's & Dementia - Wiley Online Library

Positive Data for First and Only Treatment Approved for Agitation in Alzheimer Dementia

FDA Approves First-Ever Drug for Agitation Associated with Alzheimer's Dementia